Pharmaceutical

The global pharmaceutical industry is undergoing a consolidation phase in order to combat price pressure, competition and patent cliffs. Innovation is of vital importance for steady growth of pharmaceutical companies. Pharmaceutical companies have been mainly dependent on a few blockbuster molecules. However,with rapid decline in research and development (R&D) productivity and non-conducive regulatory environment, companies need to find different avenues of growth. The patent expiry of blockbuster drugs is expected to pave way for generics. Due to difference in genetic composition of varied individuals, innovation is becoming more complex.This is influencing players offering complementary products and services to collaborate for new product development.

There are four major factors that are impacting the value creation in pharmaceutical industry:

  • Market
    • Stress from patent expiries, niche marketing, and patient-centricity is challenging the growth plans of pharmaceutical companies. Moreover, in emerging markets, companies face strong competition from local players,who sell product at a much lower cost. To counter the same global companies need to significantly reduce their profit margins.
  • Technology
    • Rapid integration of healthcare and information technology is posing threat for current blockbuster drugs
    • Products based on new technologies offer superior properties and are more efficient as compared to existing products in the market
  • Regulation
    • There is constant price pressure from governments to meet demands of growing number of patients
    • Emerging markets have regulatory uncertainty, where decisions are made to protect the interests of the general population
    • Moreover, governments, especially in emerging economies are encouraging pharmaceutical companies to focus on preventive measures for diseases, which involves major investments
  • Innovation
    • Need for innovative products or therapies is rising constantly due to rising pressure of patent-cliff coupled with reducing profit margins
    • Identification of new bacterial and viral strains is driving the need for novel drugs

Demand for personalized medicines is increasing in order to ensure effective treatment of various diseases

Investments in R&D for oncology and NCDs are increasing globally in order to provide cost-effective solutions available to ailing patients.

Market Challenges

The industry is facing certain challenges such as patent cliff, cost pressure and regulatory uncertainties across the globe. This is hindering market growth to a certain extent. Moreover, regulatory authorities are becoming more stringent with the drug approval process. However, with respect to drugs for rare diseases, the FDA has offered a fast-track approval process. Moreover, demand for cost-effective treatment for chronic and non-communicable diseases such as diabetes, hypertension, thyroid disorder, obesity, and cancer is increasing. However, there is a dearth of strong products in the pipeline that offer better treatment option with fewer side effects. The fear of side effects and long-term treatment costs is encouraging patients to shift to alternative therapies.

Combating Challenges

Market players need to combat these challenges and keep their pace with the industry to sustain their market share. Mergers, acquisitions, and divestitures of products, companies or business division is a rapidly emerging trend in the market to combat prevalent challenges in the market.Companies are more focused in terms of therapy areas and hence, are divesting less focused therapy businesses. A good example is the swap deal between GSK and Novartis in 2015.

Moreover, pharmaceutical companies are investing in consumer health products,with increasing consumer’s health awareness and emerging trend of self-medication. These trends are encouraging pharmaceutical companies to enter the OTC market and leverage their brand equity among the doctors, chemists and consumers. Companies such as GlaxoSmithKline, Cipla, Pfizer, Merck, Sun Pharma, and Abbott have a focused division or subsidiary for consumer healthcare products and markets.

Moreover, to combat increasing cost pressure, companies are evolving their distribution channel. Establishing facilities or presence through collaboration in regional markets has helped companies meet local demand with reduced costs and delivery time. Emergence of e-pharmacy has resulted in creation of a separate team in the organization to service consumers ordering medicines online. Moreover, companies are connecting with consumers through social media, which helps improve brand visibility. The distribution channel has thus evolved significantly from the decade old channel consisting of only wholesalers and physical retail shops.

Patient-centricity

Patients are increasingly becoming well informed and organized, sometimes demanding for a particular product from prescribers. Therefore, companies need to be more patient-centric in their approach and provide quality care to consumers. Pharmaceutical companies are focusing on established direct to consumer distribution channels and establishing a more strong relationship with them. Moreover, companies are creating a good purchase experience for consumers through different offerings such as post-purchase medical services, engaging the patient through social media and events, and providing regular product alerts and refilling services.

Growth in Emerging Economies

The pharmaceutical industry is rapidly expanding in emerging economies such as Asia Pacific, Africa, and Latin America. These regions possess immense potential for growth of pharmaceutical companies, owing to inadequate access to medicines, growing population and increasing incidence of non-communicable diseases (NCDs). Besides, demand for contract research and manufacturing is also high in these regions. China and India are the largest emerging markets for CRO and CMO. Companies are highly dependent on China for API supply owing to low purchase cost. Overdependence on a single country can pose a challenge for the pharmaceuticals sector in the near future. Therefore, other emerging countries such as India, Brazil and South Africa are encouraging investments in their country. Besides, global companies are establishing their facilities in Asia Pacific, Middle East and Latin America regions to enable close monitoring and servicing of lucrative regional markets.

Conclusion

Pharmaceutical companies need to focus on an integrated, patient-centric, value-driven approach along with technology integration and strategic partnerships in order to capitalize on lucrative growth opportunities in the market. Major global players in the market include Pfizer Inc., Merck & Co., Inc., Bayer AG, GlaxoSmithKline plc., Sanofi, F. Hoffmann-La Roche AG, AstraZeneca plc. and Novartis AG.

There is a paradigm shift in process in the global pharmaceutical industry from product to a ‘Prodice’ (Product and Service) model, to offer affordable, accessible and quality care to patients.

View More

Pharmaceutical Published Insights

Coherent Market Insights Clostridium Difficile Infection Treatment Market

Published Date : Jan 2023

Clostridiodes Difficile, which produces gram-positive bacterium, is an anaerobic toxin that gets transmitted through the fecal-oral route. The severe infection of clostridium difficile infection is watery diarrhea, abdominal cramping, and pain, which may be severe, de... View more

Coherent Market Insights Genetic Chronic Obstructive Pulmonary Disease Copd Market

Published Date : Jan 2023

Alpha-1 deficiency-related emphysema is called as genetic Chronic obstructive pulmonary disease (COPD) involves lung inflammation, causing obstruction of airflow from the lungs. It is a chronic illness, and some of its symptoms include wheezing, mucus production, and ... View more

Coherent Market Insights Migraine Drugs Market

Published Date : Jan 2023

Migraine is a neurological disorder often described as intense pulsing or throbbing pain in one area of the head. The pain is often unilateral and pulsating in nature, which can often be worsened by physical activity. Migraines are a type of headache that tend to caus... View more

Coherent Market Insights Anesthesia Gases Market

Published Date : Jan 2023

Anesthetic gases (isoflurane, sevoflurane, desflurane, halothane, and nitrous oxide, among others), also known as inhaled anesthetics, are administered as a primary therapy for preoperative sedation and adjunctive anesthesia maintenance to intravenous (IV) anesthetic ... View more

Coherent Market Insights Bruxism Treatment Market

Published Date : Jan 2023

Bruxism is a condition in which a person grinds, gnashes or clenches their teeth. This condition can affect adults and children and can occur during the day or night. Some people do not have any symptoms, while others may experience headaches, jaw pain, tooth pain, or... View more

Coherent Market Insights Tamiflu Oseltamivir Phosphate Market

Published Date : Jan 2023

Oseltamivir phosphate is indicated for the treatment of influenza A, influenza B, and Others. It reduces the symptoms caused by influenza virus such as stuffy nose, cough, sore throat, fever/chills, aches, and tiredness. Moreover, the medicine reduces the recovery tim... View more

Coherent Market Insights Dermatological Therapeutic Market

Published Date : Jan 2023

Dermatology is an area of medicine dealing specifically with the skin. Skin diseases have a serious impact on people's quality of life. Dermatology therapeutics are used to treat increasing cases of pigmented skin, skin resurfacing, skin tightening, and age-related de... View more

Coherent Market Insights Atopic Dermatitis Drug Market

Published Date : Jan 2023

Atopic dermatitis (AD), or eczema, is a chronic condition that causes dry, itchy, and inflamed skin. It is the most common chronic skin disease and is genetically transmitted. It can be irritating but it is not contagious. Atopic dermatitis is chronic condition and te... View more

Coherent Market Insights Anticoagulant Market

Published Date : Jan 2023

Anticoagulants are a class of drugs that help prevent blood clots. They are commonly called blood thinners. They're given to people at a high risk of getting clots, to reduce the chances of developing serious conditions such as strokes and heart attack. Anticoagulants... View more

Coherent Market Insights Anticonvulsants Market

Published Date : Jan 2023

Anticonvulsants are a broad class of drugs used to treat epileptic seizures. Since many anticonvulsants tend to operate as mood stabilizers, they are also being used more frequently to treat neuropathic pain, bipolar disorder, and borderline personality disorder. Anti... View more

Coherent Market Insights Alzheimers Disease Diagnostics And Therapeutics Market

Published Date : Jan 2023

Alzheimer’s disease is a neurodegenerative disease that usually starts slowly and progressively worsens. It is a progressive form of dementia, a continuous decline in thinking, behavioral, and social skills that disrupts a person's ability to function independen... View more

Coherent Market Insights Veterinary Excipients Market

Published Date : Jan 2023

The veterinary excipients are used in formulating the medications used in the treating animal diseases. The veterinary excipients is a substance used while formulating active ingredient of medication, included for the purpose of bulking up solid formulations, to confe... View more

Coherent Market Insights Heparin Calcium Market

Published Date : Jan 2023

Heparin calcium is calcium salt form of heparin. Heparin calcium is a negatively charged linear polysaccharide that belongs to the glycosaminoglycan family. Нeparin is an anticoagulant which is indicated for the prevention and treatment of thrombotic events such as pu... View more

Coherent Market Insights Postmenopausal Osteoporosis Market

Published Date : Jan 2023

Osteoporosis is a medical condition in which the bones become brittle and fragile due to decreased bone mass and bone mineral density, leading to frequent fragility fractures. Worldwide, one in three women over the age of 50 is at risk of developing osteoporosis. It c... View more

Coherent Market Insights Diphtheria Vaccine Market

Published Date : Jan 2023

Diphtheria is a serious infection caused by strains of bacteria called Corynebacterium diphtheriae that make a toxin. It is the toxin that can cause people to get sick. Diphtheria bacteria spread from person to person, usually through respiratory droplets, like from c... View more

Coherent Market Insights Betamethasone Acetate Market

Published Date : Jan 2023

Betamethasone acetate is an acetate ester, a steroid ester, a 17alpha-hydroxy steroid, a 20-oxo steroid, a fluorinated steroid, an 11beta-hydroxy steroid, a 3-oxo-Delta (1), Delta (4)-steroid and a tertiary alpha-hydroxyl ketone. It is functionally related to a betame... View more

Coherent Market Insights Posterior Segment Eye Disorders Market

Published Date : Jan 2023

Posterior segment eye disease (PSED) is commonly defined as diseases of the retina, choroid & optic nerve and primarily include glaucoma, age-related macular degeneration (AMD), and diabetic retinopathy (DR). The therapeutic devices are primarily used in the treat... View more

Coherent Market Insights Pancreatic Cancer Therapeutics And Diagnostic Market

Published Date : Jan 2023

Pancreatic cancer is cancer that forms in the cells of the pancreas. Pancreatic cancer occurs when changes (mutations) in the pancreas cells lead them to multiply out of control. The cancer can be diagnosed with the help of ultrasound, computerized tomography (CT) sca... View more

Coherent Market Insights Epidermolysis Bullosa Therapeutics Market

Published Date : Jan 2023

Epidermolysis bullosa is a genetic disorder characterized clinically by blister formation from mechanical trauma. There are four main types with additional sub-types identified. There is a spectrum of severity, and within each type, one may be either midely or severel... View more

Coherent Market Insights Stretch Marks Treatment Market

Published Date : Jan 2023

Stretch mark is a kind of mark that occurs when the skin stretches or shrinks swiftly. Stretch marks commonly appear on the abdomen, breasts, hips, buttocks, or other parts of the body. Stretch marks often appear during or after pregnancy and after a sudden weight gai... View more

© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.